An international survey of 766 mental health professionals across 30 countries found that 54.6% of psychotherapists are already using generative AI in their clinical work. Among those using AI, approximately 85% reported using ChatGPT, making it the most widely adopted platform in the survey.
The researchers found that therapist adoption is outpacing the development of professional guidance, training, and regulatory standards. While clinicians are increasingly incorporating AI into practice, issues such as privacy, informed consent, documentation, and appropriate clinical boundaries remain areas where clearer guidance is still evolving.
Rather than evaluating whether AI improves clinical outcomes, the study documents how quickly therapists are adopting these technologies and highlights the growing need for evidence-based standards to support their safe and responsible use.
This study suggests that generative AI is no longer an emerging technology for therapists. For many clinicians, it is already becoming part of everyday practice. The conversation is shifting from whether AI belongs in therapy to how it can be used responsibly, ethically, and within appropriate clinical boundaries.
The findings are especially relevant to Therapy AllyTM because they highlight a growing gap in the market. Many therapists are using general-purpose AI platforms that were not designed for psychotherapy and were not built around clinical workflows, therapist oversight, or structured between-session support. As AI adoption continues to grow, clinicians are likely to place greater value on tools designed specifically for mental health care, with features that support privacy, professional standards, and the therapeutic relationship.